Back

Explore every episode of the podcast Practical AI in Healthcare

Dive into the complete episode list for Practical AI in Healthcare. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.

Rows per page:

1–50 of 58

TitlePub. DateDuration
Sir Peter Donnelly of Genomics: Genetics as Nature's Drug Trial04 Oct 202600:55:07

Ninety-five percent of drug targets fail, and Professor Sir Peter Donnelly thinks the reason is simple: we can't run experiments on humans. Genetics is the next best thing. People who carry natural variants in a gene show what happens when that gene is dialed up or down over a lifetime. Peter, CEO and co-founder of Genomics, joins Steve Labkoff and Leon Rozenblit to explain how his company harmonized tens of thousands of genetic studies into one resource, what genetics revealed about "good" cholesterol, why the AI agent sits on top rather than at the core, and what genetics still can't tell a drug developer.

Travis Zack: How OpenEvidence Picks and Grades the Evidence27 Sep 202600:55:11

Doctors hallucinate too. That's the provocation Travis Zack, MD, PhD, chief medical officer of OpenEvidence, brings to this conversation with Steve Labkoff and Leon Rozenblit. A physician with 20 patients and no time to look things up goes with their gut, and can get it wrong in the same ways a language model does. Travis explains why OpenEvidence was built on retrieving evidence rather than generating answers, what makes one set of references better than another, how it grades the strength of evidence behind an answer in real time, why health systems and EHR vendors act as gatekeepers, and why the last mile of a clinical decision still belongs to a human.

Randi Seigel & Jared Augenstein: Healthcare AI Law20 Sep 202600:54:15

By Manatt’s count, more than 280 bills to regulate AI in healthcare were introduced in 2026, and almost none of the resulting law has been tested in court. Randi Seigel, a partner at Manatt who leads its health care regulatory practice, and Jared Augenstein, a senior managing director at Manatt Health, track every one of them. They join Steve Labkoff and Leon Rozenblit to map where the states are headed, explain why consent and disclosure rules often miss the mark, describe how regulation can penalize companies that tried to do the right thing, and offer practical advice on AI governance for hospitals with one-person committees and academic systems with too many.

Greg Raiz: Data-Driven Early-Stage Investing13 Sep 202600:55:28

Early-stage investing is one of the last places where big decisions get made on gut feel. Greg Raiz, co-founder and general partner of the pre-seed fund Founders Edge, is trying to change that with data: a survey of more than 3,000 entrepreneurs and a review of some 42 published studies on what predicts founder success. In a solo conversation with Leon Rozenblit, Greg explains why venture capital may be backing the wrong age group, why angel groups are structured to kill their best deals, who actually gets the leverage from AI coding tools, and why electronic medical records are ripe for disruption. Leon is a limited partner in Founders Edge and discloses it at the top of the episode.

Raihan Faroqui, MD: The Doctor at the Front Desk, AI on the Line06 Sep 202600:49:18

Raihan Faroqui trained in internal medicine and then went to work on the front desk. As VP of partnerships at Confido Health, he puts AI agents on the phone lines of what he says are about 1,500 outpatient practice sites, handling appointments, refills, insurance checks, and billing questions in twenty languages. His framing is that healthcare never had a software problem so much as a system of record problem, and agents are the first tool that does not demand a migration. In this conversation, we get into the economics of the unanswered phone call, why the deployment model looks more like consulting than software, how they define and measure agent failure, and the question the episode keeps circling: these agents do not tell patients they are agents.

S1, E50 - Jeremy Harper: The Broken Adoption Curve, Ambient Scribes Nobody Can Audit, and the Knowledge We Keep Paying For and Deleting02 Sep 202600:53:04

Every technology healthcare has adopted moved through the same curve: a bleeding-edge few went first and documented what broke, and the majority followed. Large language models skipped that entirely. Jeremy Harper, a biomedical informatician who has worked at Epic, Ohio State, and Regenstrief, and who wrote Large Language Models (LLMs) for Healthcare, explains what we gave up by going all at once. Ambient scribes are everywhere, and because most vendors discard the audio as soon as they transcribe it, nobody can say how often the notes are wrong. He offers a fix borrowed from de-identification, a one-question test for any AI vendor, and a lament for the reusable knowledge we keep paying for and deleting.

S1, E52 - Reflections #8: Year in Review30 Aug 202600:48:09

Steve and Leon close Season 1 by looking back across all fifty-two episodes. They start with what surprised them (how fast conservative institutions adopted, and how slowly AI literacy is moving), then work through five conclusions a year of guests kept reaching independently: the models are no longer the hard part, almost nobody monitors these systems after deployment, an interface built for a novice can degrade an expert, "compared to what" is the question everyone skips, and money is usually the real gate. They also notice the show has started talking to itself, with guests answering each other across dozens of episodes. Several questions are left open on purpose and handed to Season 2.

S1, E51 - Reflections #7: When the Machine Is Almost Always Right, Who Is Still Thinking?23 Aug 202600:56:19

In their seventh Reflections episode, and their fifty-first overall, Steve and Leon look back across six conversations: Mika Newton on interoperability that finally started working, Peter Embi on monitoring clinical AI after deployment, Vimla Patel on how clinicians actually reason, Renee Deehan on an engine built so it can't hallucinate, Christine Dymek on AI literacy, and Jeremy Harper on an adoption curve that broke. They decide against forcing a single grand lesson and find three threads anyway: keeping a human in the loop as a deliberate design decision, the national clearinghouse for AI errors that still doesn't exist, and whether literacy is even the right word for what healthcare workers need.

S1, E49 - Chris Dymek: Healthcare AI Literacy09 Aug 202600:50:06

Chris Dymek came to healthcare informatics by way of philosophy, and she still thinks like a philosopher: the first question is what we actually mean. As Director of Digital Healthcare Research at AHRQ, she funded AI research, helped launch work on AI and patient safety, and wrote a request for information asking healthcare organizations how they thought about AI literacy. It was never published. She left in May 2025 and carried the work into the DCI network instead. In this conversation, she lays out the distinction at the center of her framework, knowing-that versus knowing-how, the three constituencies who each need something different, and why a literate staff and a literate patient population are what let a health system move forward without breaking things.

S1, E48 - Renee Deehan: Trustworthy AI for Consumer Health02 Aug 202600:50:44

The internet is full of wellness advice built on a single cherry-picked study. Renee Deehan, a molecular and cell biologist who leads science and AI at InsideTracker, spent two decades building the opposite. In this episode, she explains why the core of their recommendation engine is symbolic AI, knowledge representation and reasoning, rather than a large language model: it's deterministic, fully auditable, and by design cannot hallucinate. The LLMs are fenced off to chat and summaries, while humans still write and review every recommendation against convergent clinical evidence. She and the hosts dig into a 20,000-user outcomes study, the discipline of refusing to claim causality, the MCT-oil case where the system decides not to recommend, and how a data-science team grew its own AI literacy instead of hiring it.


S1, E47 - Vimla Patel: Cognitive Science of Clinical Reasoning26 Jul 202600:54:05

Dr. Vimla Patel has spent four decades studying how physicians actually reason, and what happens when technology ignores it. In this episode, she explains the difference between forward reasoning (the fast, pattern-driven hallmark of expertise) and backward reasoning (the slower, hypothesis-testing mode of novices), and why most clinical AI is built for the wrong one. Through two vivid cases, a textbook expert diagnosis and a near-fatal potassium overdose driven by a flawed order-entry system, she shows how good design preserves clinical judgment and bad design erodes it. She closes with a warning about confident AI and the quiet loss of independent thinking.

S1, E46 - Peter Embi: The Doctor Who Diagnosed Himself19 Jul 202600:57:46

Peter Embi has spent his career at the intersection of medicine and informatics: coining the term "algorithmovigilance," serving as the nation's first Chief Research Information Officer, and leading AI work at Vanderbilt. He is also a patient. A rare adrenal tumor took nearly 15 years and a self-diagnosis to catch, and it nearly killed him. In this conversation, Embi connects that diagnostic odyssey to the case for monitoring clinical AI the way we monitor drugs: continuously, in the real world, across a network of institutions. The discussion runs from zebras and missed diagnoses to VAMOS, the "air traffic control tower" his team built to keep deployed models honest.

S1, E45 - Mika Newton, xCures: Intelligent Interoperability12 Jul 202600:53:42

Interoperability has been healthcare's twenty-year broken promise, but something genuinely changed. Mika Newton, CEO of xCures, explains how provider data exchange jumped from roughly 30% to 85–90% in just two years, and why that's only half the story. Moving records, it turns out, was never the hard part. As Newton puts it, "records travel, but they don't translate" — most of a record arrives as duplicated notes and scanned images that still have to be made usable. Steve and Leon dig into the honest limits of AI parsing, the card-network model behind nationwide exchange, and why the patient is becoming the real access point to their own data.

S1, E44 - Reflections #6: After Five Episodes, What Still Has to Be Human?05 Jul 202600:48:44

In their sixth Reflections episode, Steve and Leon look back across five conversations (Sarah Rossetti, Jeff Smith of ONC, Hugo Campos, Fred Bennett, and Zak Kohane) and decide, deliberately, not to force a single grand theme. What surfaces anyway is one question asked five ways: as AI gets genuinely capable, what still has to be human, and what makes it trustworthy? They cover Rossetti's CONCERN system that models the nurse instead of the patient, ONC giving AI agents patient-like data rights, the tension between patient empowerment and black boxes you don't understand, the Minimum Trustable Product, and Kohane's method for measuring the values a healthcare AI actually acts on. A practical tour of where good is starting to look real.

S1, E43 - Isaac "Zak" Kohane, MD, PhD (Chair, Biomedical Informatics, Harvard Medical School; founding Editor-in-Chief, NEJM AI)28 Jun 202600:57:44

A quiet war is underway over who controls your health data in the age of AI, and the front-runners aren't the usual suspects. Dr. Isaac "Zak" Kohane, Chair of Biomedical Informatics at Harvard Medical School and founding editor of NEJM AI, traces the line from SMART on FHIR (the accidental standard he helped create in 2009) to today's battle for the doctor-facing AI layer, where companies like OpenEvidence are outrunning the EHR incumbents. He also unveils his Human Values Project, which measures the values embedded inside clinical AI models, and warns how easily payers and pharma could tune them. A two-act conversation about freeing data and guarding values.

S1, E42 - Live with Fred Bennett, Founder & CEO, PatientTalker21 Jun 202600:58:32

For its first-ever live episode, recorded before an audience at New York Tech Week, Practical AI in Healthcare sits down with Fred Bennett, founder and CEO of PatientTalker — an ambient-AI app built for the patient rather than the clinician. (Steve Labkoff is a disclosed advisor to the company.) Bennett traces the idea to his father's cardiology visit, where three family members left with three different memories of the same conversation. The discussion covers why patients are the forgotten end-user of clinical AI, how to build a "minimum trustable product," the honest question of who pays for patient-first tools, and why the technology is rarely the hard part.

S1, E41 - Hugo Campos: Patient-Directed AI14 Jun 202600:51:37

Patient advocate Hugo Campos spent more than a decade fighting for access to the data from his own implanted defibrillator. When the system wouldn't budge, he stopped trying to reform it and started building around it. In this episode, Hugo shows how he used agentic AI coding tools to create OpenKP, an open-source app that liberates his records from inside Kaiser Permanente, despite calling himself a non-coder. He and the hosts unpack the line between institutional AI and patient-directed AI, the discipline of having two AIs check each other, and why he believes "critical AI health literacy" now matters more than knowing how to code.

https://practicalaiinhealthcare.com/

S1, E40 - Jeff Smith — AI Regulation, Transparency & Innovation from the Government Perspective07 Jun 202600:43:40

What happens when the rules for getting AI into clinical care are written by someone who has spent his career inside both the advocacy world and the government? In this episode, we talk with Jeff Smith of ONC at HHS, the first government official on Practical AI in Healthcare. Smith walks us through ONC's proposed HTI-5 rule, including a striking move to treat AI agents as "users" with the same data-access rights as clinicians, and a new question about whether blocking data from being written back into the EHR is itself information blocking. We also dig into the limits of what a regulator can actually do, and why the real work is coordination across agencies rather than control from any one of them.

https://practicalaiinhealthcare.com/

https://www.youtube.com/@PracticalAIinHealthcare

S1, E39 - Sarah Rossetti, RN, PhD: Nursing Informatics & the CONCERN Early Warning System31 May 202600:53:05

On National Nurses Day, Practical AI in Healthcare welcomes its first nurse: Sarah Rossetti, RN, PhD, of Columbia University. Her CONCERN early warning system takes an unusual approach to predicting patient deterioration. Instead of modeling a patient's vital signs and labs, it models the nurse's documentation behavior, since the frequency and timing of charting reflect clinical concern long before the numbers move. In a 74-unit randomized trial of more than 60,000 patients, published in Nature Medicine, CONCERN was associated with a 35.6% reduction in instantaneous mortality risk. Rossetti and the hosts unpack the method, the counterintuitive rise in ICU transfers, equity safeguards, and what ambient AI means for the signal.


https://practicalaiinhealthcare.com/episodes/#S1E39

More on Sarah Rossetti's work: https://www.dbmi.columbia.edu/profile/sarah-collins-rossetti/

S1, E38 - Reflections 5: How Specialized Does AI Have to Be to Actually Work?24 May 202600:34:55

In their fifth Reflections episode, Steve and Leon look back across six conversations (Matt Truppo at Sanofi, Ted Shortliffe, Barry Chaiken, David Hidalgo-Gato, and Danny van Leeuwen) to ask a sharper question: how specialized does AI have to be to actually work? The throughline is depth. The LLM is a commodity, and so, increasingly, is the generalist agent. What stays scarce is specialization in a workflow, the revival of symbolic methods like knowledge graphs, the literacy that separates an AI's ~95% solo accuracy from the under-35% people get using it themselves, and leaders willing to use themselves as the test rig. After 37 episodes, the technology is no longer the question. The specificity of the work around it is.

S1, E37 - Danny van Leeuwen, MPH, RN, Health Hats: Patient's POV on AI Tools17 May 202600:42:22

Danny van Leeuwen is a nurse of 50 years, a multiple sclerosis patient, host of the Health Hats podcast, and a serial member of national outcomes panels at CMS, AHRQ, PCORI, and the National Academy of Medicine. He has tried more than 100 health apps and uses five. In this episode, he explains how he uses AI to interrogate his own chart, surface symptom patterns, and prepare for clinical encounters, and he shares his Three T's and Two C's framework for evaluating any digital health technology: Time, Trust, Talk, Control, Connection. The conversation covers what patients want from AI, what they do not, and why pain, fear, and cognition still escape the data.

S1, E36 - David Hidalgo-Gato, Founder & CEO, Cleo Health: Going a Mile Deep on Emergency Medicine — Specialization, Design Partnerships, and the Acute Care OS10 May 202600:49:33

David Hidalgo-Gato is the founder and CEO of Cleo Health. While more than 100 competitors were building generic ambient AI scribes, David's team chose emergency medicine and stayed with one design partner for nine months and roughly 50 product iterations before launching. The result: an average 54-minute time savings per shift, a patient-assignment tool that turned a four-hour process into 15 to 20 minutes, and use across 400+ hospitals nationwide. The conversation covers why ED workflow breaks generic ambient scribes, why generative AI fits patient assignment specifically, and David's argument that workflow understanding is the moat AI cannot commoditize.

https://practicalaiinhealthcare.com/

S1, E35 - Barry P. Chaiken, MD, MPH: Physician-as-Patient Perspective on AI in Healthcare03 May 202600:53:30

When physician Barry Chaiken was diagnosed with prostate cancer, his clinical training gave way to fear. It took a friend asking, "What are you doing?" to snap him back into doctor-mode thinking. That experience reshaped how he sees AI in healthcare. In this episode, Chaiken draws on his dual perspective as physician and two-time cancer survivor to argue that consumer health AI is failing patients, not because the models are bad, but because patients don't know how to use them. He shares a practical framework for AI-assisted patient education, makes the case for an aviation-style safety reporting system for healthcare AI, and explains why interoperability is an incentive problem, not a technology problem.

S1, E34 - Matt Truppo, PhD, Part 2: AI-Driven Drug Development at Sanofi: Clinical Trials, Regulatory, and Personal AI26 Apr 202600:56:47

In Part 2 of our conversation with Matt Truppo, Global Head of Research Platforms and Computational R&D at Sanofi, we move from discovery to development, where the real stakes begin. Matt unpacks the promise and limitations of “digital patient twins,” a concept often described as the holy grail of drug development. With nearly 90% of drugs failing in clinical trials, even modest gains in predicting efficacy or patient response could transform the industry. Through real-world examples, including Dupixent and rare disease therapies, Matt shows how quantitative systems pharmacology (QSP) and AI-driven simulations are already shortening timelines, reducing patient burden, and, in some cases, eliminating the need for entire trials.

But the story doesn’t stop at modeling. We explore how AI is reshaping clinical operations, from Sanofi’s “clinical control tower” that integrates trial data across 4,000 users, to generative AI tools that are cutting regulatory document creation time by more than a third. Matt also shares a personal experiment, building a network of AI agents modeled on his own workflow, reclaiming 30% of his time and offering a glimpse into a more “agentic” future of work. The throughline is clear: AI is not replacing human expertise, but amplifying it, helping the industry finally bend the cost and time curve of drug development.

S1, E33 - Ted Shortliffe, MD, PhD: 50 Years of Clinical AI19 Apr 202600:48:25

Ted Shortliffe built MYCIN at Stanford in the 1970s, one of the first medical AI systems ever deployed in a clinical setting. Five decades later, he joins Steve and Leon to examine what has persisted in clinical decision support — above all, the demand for explainability — what has changed (computational power finally caught up to the ideas), and what the field may have lost along the way. The conversation includes a direct response to Bob Wachter's claim from S1E24 that AI in healthcare decision support was "too hard a problem to start with," and a case for why structured knowledge representation deserves a second look in the age of LLMs. For anyone tracing the arc of medical AI history, this episode is a rare primary source.

S1, E32 - Matt Truppo, PhD: AI-Driven Drug Discovery at Sanofi12 Apr 202600:52:33

AI in drug discovery has been long on promise and short on delivery. Matt Truppo, Global Head of Research Platforms and Computational R&D at Sanofi, presents a different picture. His team used AI to identify 10+ novel drug targets in 12 months, screen 30 million target combinations in days, and produce AI-designed compounds with 75% synthesizability. But Truppo is equally candid about the gaps: data integration, explainability, and change management remain real barriers. In Part 1 of this two-part conversation, hosts Steve Labkoff and Leon Rozenblit explore what happens when AI moves past pilot projects into core pharmaceutical science.

S1, E31 - Reflections 4: What Does the Infrastructure Actually Look Like?05 Apr 202600:51:35

Every five episodes, Steve and Leon step back to examine what picture forms when you put their guest conversations side by side. This time, five guests from completely different healthcare domains -- data quality, clinical trials, medical translation, patient data, participatory medicine -- independently converged on the same conclusion: the AI works; the infrastructure around it doesn't yet. From Charlie Harp's data quality metrics to Adam Blum's 60-to-90% scaffolding story to Amy Price's reframing of healthcare AI as "unfinished, not broken," Block 4 reveals what industry maturation actually looks like -- not a breakthrough, but a quiet shift in what the conversation is about.

S1, E30 - Amy Price: Patient Advocacy, Participatory Medicine, and AI Governance29 Mar 202600:58:57

Amy Price survived a car accident that left her with a broken neck, severe brain injury, and $4 million in medical bills. She was told she'd need to be institutionalized. Instead, she earned a DPhil at Oxford and became Editor-in-Chief of the Journal of Participatory Medicine. In this episode, Amy sits down with Leon to discuss why patients belong inside the AI design process, what it really means to have a "knowledgeable human who cares" in the loop, and why healthcare AI is an unfinished system worth building on, not a broken one worth scrapping. She also shares how she uses AI tools for her own health decisions and what she's learned about closing the patient AI literacy gap.

S1, E29 - Shashi Shankar, Co-founder & CEO, Novellia, Inc.22 Mar 202600:53:37

Shashi Shankar spent nearly a decade at Genentech before a family cancer journey and a broken data landscape pushed him to build something different. His company Novellia works directly with patients — not data brokers — to collect and consolidate health records across multiple providers using SMART on FHIR. The result: longitudinal, patient-authorized real-world data that fills the gaps left by claims databases, single-site EMRs, and health information exchanges. We explore why previous PHR companies failed, how AI catches clinical data errors that humans miss, and whether Big Tech should be trusted with patient data.

S1, E28 - Adam Blum: AI-Powered Clinical Trial Matching15 Mar 202600:50:37

When Adam Blum was diagnosed with follicular lymphoma, he tried over a dozen commercial trial matchers. None returned actual matches. So the serial AI entrepreneur built CancerBot, a free precision-matching service that assesses 100% of eligibility criteria — not the five surface-level attributes most matchers use. On this episode, Blum explains the Prompt Workbench (where biomedical experts refine extraction prompts to above 90% accuracy), how conjunctive normal form makes complex eligibility logic tractable, and why "best trial" means something different for every patient. A masterclass in AI scaffolding for healthcare.

S1, E27 - Charlie Harp, Healthcare Data Quality and the PIQI Framework08 Mar 202600:48:28

For 37 years, Charlie Harp heard the same thing from healthcare organizations: "Our data quality is fine." They were right — for billing and scheduling. But AI changed the equation. Harp, founder of Clinical Architecture, built the PIQI framework to measure patient data quality across four dimensions: availability, accuracy, conformance, and plausibility. His PIQXL Gateway scores data on a 1-100 scale before it enters your systems — not after. Early deployments reveal uncomfortable truths: lab data averages 70% quality against USCDI standards, and one facility coded every blood test to a single LOINC code. The framework is now going through HL7 balloting as an open national standard.

S1, E26 - Discharge Planning Translation Services with Giovanni Donatelli01 Mar 202600:45:40

Every day, patients leave US hospitals with discharge instructions they can't read. Giovanni Donatelli, CEO of The Language Group, built FETCH — a patented AI system embedded in Epic that translates discharge documents in 15 minutes with human review. He did it because he was the 8-year-old interpreting for his immigrant parents at doctor's appointments. Hosts Steve Labkoff and Leon Rozenblit explore the discharge instruction gap, the tragic cases that make it personal, FETCH's three-layer translation pipeline, the case for keeping humans in the loop, and why healthcare executives think they've already solved a problem that doesn't yet have a solution.

S1, E25 - Reflections 3: What Happens When Principles Meet Reality22 Feb 202600:45:48

Steve and Leon have reviewed blocks of guest episodes twice before on Practical AI in Healthcare. Both times the themes snapped into place. This time they didn't -- and the disagreement between them became the episode. Across five recent conversations, they found stories that kept spilling past the edges of their framework: AI that works but can't get paid, laws that already apply but nobody realizes it, and a scientific record under threat from AI-generated paper mills. The hosts' attempt to make sense of it all reveals where their thesis holds, where it breaks, and what needs to change.

S1, E24 - Bob Wachter, MD | A Giant Leap: AI in Healthcare15 Feb 202600:54:52

Bob Wachter wrote the book on the EHR disaster. Now he's written one about AI.

The UCSF Chair of Medicine joins hosts Steve Labkoff and Leon Rozenblit to discuss A Giant Leap, his argument that AI doesn't need to be perfect—it needs to beat a healthcare system already failing at scale. They cover Watson's $3B collapse, why ambient scribes became AI's first clinical success story, the human-in-the-loop problem that nobody has solved, and the dangerous gap between how experts and novices use AI tools.

Key topics: productivity paradox, complementary innovations, clinical decision support design, AI literacy, and the "compare me to the alternative" thesis.


The link to the book can be found here: https://a.co/d/07JFNwIw


S1, E23 - CHiRP: AI-Enabled Early Detection of Psychosis Risk with Amar Mandavia, PhD & Enrique "Kike" Gutiérrez, PhD08 Feb 202600:45:24

What if early signs of psychosis could be detected from how patients speak—not what they say, but how they organize their thoughts?

Amar Mandavia (VA Boston, Boston University) and Enrique "Kike" Gutiérrez (Polytechnic University of Madrid) join hosts Steve Labkoff and Leon Rozenblit to discuss CHiRP, an AI tool that identifies formal thought disorder from routine clinical conversations. They explain why the gold-standard manual test takes 5+ hours, how their system reduces that to minutes, and the hard ethical questions around labeling patients as "at risk."

Key topics: prodromal psychosis detection, NLP in mental health, clinical workflow integration, MIT linQ Catalyst, and the payer challenges that make prevention hard to fund.

S1, E22 - Aaron Kamauu, MD, MS, MPH | RWE Design in the Age of Data01 Feb 202600:50:42

Real-world evidence was supposed to accelerate drug development. Instead, we've created definitional chaos—over 100 data vendors, inconsistent definitions, and studies that can't be compared.

Dr. Aaron Kamauu, CEO of Navidence and co-host of Real World Wednesday, explains why one missing diagnosis code can exclude 30% of your cohort, how GLP-1 eligibility criteria vary wildly between NHS and US guidelines, and what it means to document "the seven definitions you chose NOT to use."

A conversation about the unsexy infrastructure that makes evidence trustworthy.


S1, E21 - Jeff Chuang, PhD, The Jackson Laboratory25 Jan 202600:48:17

In this episode of Practical AI in Healthcare, we sit down with Dr. Jeff Chuang, a computational biologist at The Jackson Laboratory, to explore how AI is reshaping cancer diagnostics, starting with pediatric sarcoma. Jeff shares his journey from physics and protein folding to computational pathology, where machine learning is being applied to standard H&E pathology slides to deliver faster, cheaper, and more accurate diagnoses.

The conversation dives into how AI models trained on relatively small but carefully curated image datasets can outperform traditional diagnostic approaches, especially in rare cancers where expertise is scarce. We also explore the challenges of data sharing, IRB approvals, and real-world deployment, along with a glimpse into the future of spatial genomics and ultra-high-resolution tissue analysis. This episode is a powerful example of how practical AI can directly improve patient care today.


S1, E20 - Josh Geleris, MD, CPO, SmarterDx18 Jan 202600:51:42

In this episode of Practical AI in Healthcare, we sit down with physician–informaticist Josh Geleris, MD, co-founder and Chief Product Officer of SmarterDx, to unpack one of healthcare’s most overlooked AI opportunities: revenue cycle intelligence. Drawing on his clinical training, deep technical background, and firsthand experience inside large health systems, Josh explains how AI can bridge the gap between clinical reality and billing documentation. The conversation explores how machine learning and large language models translate thousands of data points from an inpatient stay into accurate, compliant coding, helping health systems reduce revenue leakage while staying firmly within regulatory guardrails. From SQL queries to post-trained LLMs, Josh walks us through the evolution of SmarterDx’s AI stack and why human-in-the-loop design remains essential. This is a grounded, practical look at AI delivering real value where healthcare operations and clinical truth collide.

S1, E 19 - Dr. Alvin Liu and AI Diabetic Retinopathy Screening11 Jan 202600:48:09

In this episode of Practical AI in Healthcare, we sit down with Dr. Alvin Liu, retinal surgeon and Professor of Artificial Intelligence and Ophthalmology at Johns Hopkins University, to explore one of the earliest and most successful real-world deployments of medical AI.

Dr. Liu walks us through the evolution of autonomous AI for diabetic retinopathy screening, from FDA approval to large-scale clinical implementation across health systems. We unpack what it really takes to move AI from validation to impact, including workflow integration, sensitivity and specificity tradeoffs, reimbursement challenges, and post-market monitoring. The conversation also looks ahead to emerging AI applications using retinal imaging to predict cardiovascular disease, dementia, and kidney disease at the population level.

This episode is a masterclass in how AI can meaningfully improve access, equity, and outcomes in healthcare when deployed thoughtfully and responsibly.


S1, E18 - Tiffany Leung, MD - Scientific Editorial Director, JMIR04 Jan 202600:47:24
  • In this episode of Practical AI in Healthcare, we sit down with Dr. Tiffany Leung, Scientific Editorial Director at JMIR Publications, to explore how artificial intelligence is reshaping scientific publishing from the inside out. As open access journals face unprecedented volumes of submissions, AI is simultaneously enabling faster discovery and creating new challenges around research integrity, peer review, and trust in the scientific record.

  • Tiffany shares how journals are adapting to generative AI tools, from policy development and disclosure norms to editorial decision support systems that help identify potential risks without stifling innovation. The conversation moves beyond hype to examine how AI can act as a co scientist, streamline editorial workflows, and potentially redefine peer review itself. This episode offers a rare look at how AI is influencing not just what gets published, but how knowledge is validated and shared globally.


    S1, E17: Kathy Roe & Kenny White: The Legal Realities of AI in Healthcare21 Dec 202500:52:17

    In this episode, Steven Labkoff and Leon Rozenblit explore the legal, regulatory, and risk-management challenges introduced by AI with two top experts in the field: Kathy Roe, Principal at Health Law Consultancy, and Kenny White, Director of the Managed Care Industry Group at Alliant Insurance Services.

    Together, they unpack how AI intersects with medical malpractice, product liability, HIPAA privacy, de-identification, intellectual property, contractual risk, and insurance coverage. Kathy and Kenny explain why AI is not yet the standard of care — but why clinicians and health systems must develop AI literacy now as the legal landscape evolves.

    A must-listen episode for healthcare leaders navigating the risks and realities of AI adoption.

    S1, E16: Reflections II - Episodes 9-1514 Dec 202500:48:46

    In our second Reflections episode, Steve Labkoff and Leon Rozenblit synthesize the most meaningful insights from guests across Episodes 9–15. Drawing on conversations with Orr Inbar, Martin Leach, Ing Ho, Yuri Quintana, and patient advocate E-Patient Dave, this episode highlights the themes shaping practical AI adoption in today’s healthcare landscape.

    Key topics include the inflection point AI has created across clinical care, research, and patient engagement; the need for stronger data stewardship to support trustworthy automation; and the emerging promise of AI-driven clinical trial optimization and simulation. We also explore how patients are engaging with AI tools independently, raising new questions about literacy, safety, and empowerment.

    Additional themes include the cultural alignment required for tools like ambient listening and chart summarization to succeed and what it will take for AI to avoid the missteps of past health-IT transitions.

    The episode closes with a preview of upcoming guests discussing AI in law, payer innovation, psychiatric diagnostics, and the future of scientific publishing.



    S1, E15 - Adam Rodman: Rethinking Clinical Reasoning in the Age of AI07 Dec 202500:43:09

    We just released one of the most intellectually energizing conversations we’ve had on Practical AI in Healthcare. Our guest this week is Dr. Adam Rodman, physician, informatician, historian of medicine, and one of the most original thinkers at the intersection of AI and clinical reasoning.

    Adam brings a rare perspective to the field: before becoming an AI researcher, he spent years studying how humans make medical decisions — how clinicians reason, where cognition breaks down, and how technology reshapes the way we conceptualize disease. His reflections on the evolution from QMR and INTERNIST-1 to today’s large language models are a must-hear.

    In this episode, we explore:
    • Why LLMs challenge 50 years of clinical decision support assumptions
    • New collaboration models for doctors, patients, and AI — not just “human in the loop,” but truly redesigned workflows
    • What’s holding back clinical AI adoption (spoiler: it’s not accuracy)
    • The regulatory gap—and why the FDA’s old device mindset won’t work for generative models
    • How urgent-care AI companies are early signals of a broader shift

    Adam also discusses what the next 3–5 years may actually look like — and why change will be slow…until the moment it becomes very fast.

    Listen here and join the conversation on the future of practical, safe, and human-centered AI in healthcare.


    Apple Podcasts: https://podcasts.apple.com/us/podcast/practical-ai-in-healthcare/id1837172964

    Spotify: https://open.spotify.com/show/63NBSNTdKsLHO7jmNxiZHv?si=277e9a14c24f41d9

    Amazon Podcasts: https://music.amazon.com/podcasts/8ed0ba60-15f4-419b-85f1-c4b85af81b41/practical-ai-in-healthcare


    #HealthcareAI, #ClinicalAI #MedicalInformatics #ClinicalDecisionSupport #AIinMedicine #DigitalHealth #HealthTech #FutureOfHealthcare #GenerativeAI #AIGovernance #DiagnosticExcellence #PatientCareInnovation #HealthcareTransformation #AIThoughtLeadership #PracticalAI

    S1, E14 - Orr Inbar, CEO Quant Health - AI Simulations of Clinical Trials30 Nov 202500:44:23

    Practical AI in Healthcare just released one of our most eye-opening conversations yet, featuring Orr Inbar, CEO & Co-Founder of QuantHealth.

    QuantHealth is pushing the boundaries of what’s possible in clinical development with AI-driven clinical trial simulation. Orr walked us through how modern deep learning, massive biological knowledge graphs, and patient-level real-world data can now simulate clinical trials with 80–90% accuracy — across dozens of indications, modalities, and trial phases.

    In our conversation, we cover:

    • How QuantHealth models patient-drug interactions at massive scale
    • Why trial design is still the most critical (and fixable) failure point in drug development
    • How simulation is becoming the new starting point for protocols
    • What AI-first trial design could mean for speed, cost, and reducing avoidable trial failures
    • Where the field is headed in the next 5–10 years — including the provocative question of how far simulation can replace human trials

    Orr also discusses the acceleration of biological data, the maturity of real-world data, and transformer-based AI — the perfect storm that made this moment possible.

    This is one of the best deep dives yet into the practical future of drug development.

    S1, E13 - Part 2 of 2: Dr. Yin Ho's discussion of her new book, Rushing Headlong: Health IT’s Legacy and the Road to Responsible AI23 Nov 202500:46:38

    In the conclusion of our two-part conversation with Dr. Yin Ho, author of Rushing Headlong: Health IT’s Legacy and the Road to Responsible AI, we explore how healthcare can avoid repeating its digital past. Dr. Ho and hosts Dr. Steven Labkoff and Dr. Leon Rozenblit dive into small language models, decision support vs. decision control, the pitfalls of ambient scribing, and why “rage-building” the next generation of EHRs might be the most responsible act of all.


    S1, E12: Part 1 of 2: Dr. S. Yin Ho discusses her new book16 Nov 202500:49:24

    The newest episode of Practical AI in Healthcare features Dr. Yin Ho—physician, entrepreneur, and author of Rushing Headlong: Health IT's Legacy and the Road to Responsible AI.

    In Part 1 of our two-part conversation, Dr. Ho joins Dr. Steven Labkoff and Dr. Leon Rozenblit to unpack 25 years of digital health transformation—from the dawn of electronic medical records to the market and policy forces that shaped today’s health IT landscape.

    Together, we explore how well-intentioned decisions created a fragmented system that prioritizes billing over care—and why understanding that history is essential to building a responsible AI future.

    #HealthcareAI #DigitalHealth #HealthIT #PracticalAIinHealthcare #Podcast

    S1, E11: Dr. Yuri Quintana from the DCI Network reviews our latest Meeting09 Nov 202500:40:49

    Dr. Yuri Quintana, Director of the Division of Clinical Informatics at Beth Israel Deaconess Medical Center, joins us this week to discuss the DCI Network’s mission: turning AI in healthcare from theory into practice.
    The conversation traces DCI’s evolution as a multi-stakeholder “action tank” focused on collaboration, transparency, and patient safety. Quintana recounts the success of the Signal Through the Noise conference and the insights that emerged—chief among them that “mundane AI” (like triage, scheduling, and documentation tools) is quietly creating real value.
    The episode also explores topics like AI literacy, governance, transparency (“AI nutrition (model) labels”), and post-market surveillance for clinical AI—ending with a call to action: keeping healthcare innovation grounded in what truly matters to patients.

    S1, E10: AI in Healthcare: A Patient's Perspective with ePatient Dave02 Nov 202500:50:47

    In this episode of Practical AI in Healthcare, Dr. Steven Labkoff and Dr. Leon Rozenblit speak with ePatient Dave DeBronkart, a globally recognized advocate for patient empowerment.

    Dave shares his journey from a life-threatening kidney cancer diagnosis in 2007 to becoming one of the earliest champions of open data, patient access to medical records, and of late, patient use of AI tools to help empower them along their medical journey.


    He recounts how the ability to access information, share data, and join online patient communities helped save his life—and how those lessons now translate into how patients use generative AI. Dave highlights stories where AI enabled patients to identify rare diagnoses, manage health conditions, and even prepare for clinical visits.


    The discussion examines how AI literacy and trust can empower patients, the ethical boundaries of sharing health data, and the evolution of patient–clinician partnerships in the era of AI.

    S1, E9: Martin Leach, PhD, MBA, CDO of Black Canyon Consulting26 Oct 202500:43:20

    This week’s episode of Practical AI in Healthcare dives into AI, truth, and the future of data in the government with Dr. Martin Leach, Chief Data Officer at Black Canyon Consulting.

    Dr. Martin Leach, PhD, is a data, science, and technology leader with a career spanning some of the most innovative organizations in life sciences and academia. A self-described “data geek,” Martin began his career as a molecular neuropharmacologist before shifting from the bench to data-driven discovery. Over the past two decades, he has held senior roles at Merck, Biogen, Alexion, and AstraZeneca, and was the inaugural Chief Information Officer at the Broad Institute of MIT and Harvard.

    Today, Martin serves as Chief Data Officer at Black Canyon Consulting, where he works these organizations on projects that unite bioinformatics, AI, and data federation — from building semantic knowledge graphs to creating “gold-standard” datasets for model validation. His work bridges the worlds of science, computation, and policy, shaping how government and industry can responsibly harness AI to advance biomedical research and healthcare delivery.

    From building gold-standard datasets to exploring quantum AI, Martin shares how these projects are shaping the next generation of healthcare data science.

    S1, E8: Reflections on Our First 7 Episodes19 Oct 202501:02:19

    In this week's episode, Leon and Steve unpack and digest the various pearls provided by our first 7 podcasts. From frameworks to consider concerning AI in the business and healthcare setting to AI Literacy, we highlight the various lessons learned as we move into our third month of the Podcast.

    © My Podcast Data · Independent project · Data from Apple & Spotify